Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Aggregates Not Visible with Naked Eye Detected in Kenacort
April 6, 2009
- Mr Matsutani to Step Down as FJPWA President
April 6, 2009
- Pfizer Announces Results of EPPV on Sutent
April 6, 2009
- NEW PRODUCTS
April 6, 2009
- Greater Hypotensive Effects Can Be Expected with Co-DIO: Dr Ogihara
April 6, 2009
- BUSINESS NEWS IN BRIEF
April 6, 2009
- Selective a1-Inhibitors Effective against MS-Associated Dysuria: Prof. Horie
April 6, 2009
- Market Growth for Generics Slowed Down in 4th Qtr of 2008
April 6, 2009
- Treatment of AD/HD HasReached a Stalemate: Prof. Tanaka
April 6, 2009
- 1st Seminar to Promote Use of Generics Held
April 6, 2009
- JSHP Concerned about Exposure of Pharmacists to Anticancer Drugs
April 6, 2009
- Korosho's Survey Confirms Low Generic Substitution Rate
April 6, 2009
- Increases in People's Financial Burden Are Inevitable: MOF
April 6, 2009
- 78.6% of Pharmacies Obtain Premium for Dispensing Generics
April 6, 2009
- Awareness Rate for CKD only 10%: Healthclick
April 6, 2009
- Daiichi Sankyo Sues 13 Companies for Levofloxacin Patent Violation
April 6, 2009
- JSMO Aims at Health Insurance Coverage of KRAS Gene Testing
April 6, 2009
- Many Patients Hesitate to Request Generic Substitution
April 6, 2009
- Synergism with Millennium to Drive Takeda's Business in Oncology
April 6, 2009
- 12 Drugs and 5 APIs Priced
April 6, 2009
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…